Structural basis of mouse cytomegalovirus m152/gp40 interaction with RAE1γ reveals a paradigm for MHC/MHC interaction in immune evasion

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 51, 2012, Pages 3578-3587

  Wang, Rui ^a   Natarajan, Kannan ^a   Revilleza, Maria Jamela R ^a   Boyd, Lisa F ^a   Zhi, Li ^a,d   Zhao, Huaying ^b   Robinson, Howard ^c   Margulies, David H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Immune recognition; Virus evasion; X ray diffraction

Indexed keywords

CYTOMEGALOVIRUS PROTEIN M152; GLYCOPROTEIN; GLYCOPROTEIN GP 40; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; RETINOIC ACID EARLY INDUCIBLE 1 GAMMA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; IMMUNE EVASION; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

ANIMALS; DROSOPHILA; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HUMANS; IMMUNE SYSTEM; KILLER CELLS, NATURAL; LIGANDS; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR CONFORMATION; MUROMEGALOVIRUS; MUTATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; NUCLEAR MATRIX-ASSOCIATED PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; PROTEIN CONFORMATION; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; SURFACE PLASMON RESONANCE; VIRAL PROTEINS; X-RAY DIFFRACTION;

CYTOMEGALOVIRUS; RODENTIA;

EID: 84871358759     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1214088109     Document Type: Article

References (55)

1. Reddehase MJ (2002) Antigens and immunoevasins: Opponents in cytomegalovirus immune surveillance. Nat Rev Immunol 2(11):831-844.
2. Sissons JG, Carmichael AJ, McKinney N, Sinclair JH, Wills MR (2002) Human cytomegalovirus and immunopathology. Springer Semin Immunopathol 24(2):169-185.
3. Lenac T, Arapović J, Traven L, Krmpotić A, Jonjić S (2008) Murine cytomegalovirus regulation of NKG2D ligands. Med Microbiol Immunol (Berl) 197(2):159-166.
4. Lanier LL (2008) Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8(4):259-268.
5. Jonjić S, Babić M, Polić B, Krmpotić A (2008) Immune evasion of natural killer cells by viruses. Curr Opin Immunol 20(1):30-38.
6. de Kruijf EM, et al. (2012) NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: An observational study. BMC Cancer 12:24.
7. McGilvray RW, et al. (2010) ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients. International Journal of Cancer 127(6):1412-1420.
8. Cerwenka A, et al. (2000) Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12(6):721-727.
9. Carayannopoulos LN, Naidenko OV, Fremont DH, Yokoyama WM (2002) Cutting edge: Murine UL16-binding protein-like transcript 1: A newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol 169(8):4079-4083.
10. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH (2000) Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1(2):119-126.
11. Li P, McDermott G, Strong RK (2002) Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. Immunity 16(1):77-86.
12. Radaev S, Rostro B, Brooks AG, Colonna M, Sun PD (2001) Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity 15(6):1039-1049.
13. Lodoen M, et al. (2003) NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med 197(10):1245-1253.
14. Krmpotic A, et al. (2005) NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 201(2):211-220.
15. Lodoen MB, et al. (2004) The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med 200 (8):1075-1081.
16. Krmpotić A, et al. (2002) MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol 3(6):529-535.
17. del Val M, et al. (1992) Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J Exp Med 176(3):729-738.
18. Ziegler H, et al. (1997) A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6(1):57-66.
19. Mans J, et al. (2009) Structure and function of murine cytomegalovirus MHC-I-like molecules: How the virus turned the host defense to its advantage. Immunol Res 43(1-3):264-279.
20. Arapović J, Lenac Rovis T, Reddy AB, Krmpotić A, Jonjić S (2009) Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60. Mol Immunol 47(1):114-122.
21. Zhi L, et al. (2010) Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. Biochemistry 49(11):2443-2453.
22. Mans J, et al. (2007) Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153. J Biol Chem 282(48):35247-35258.
23. Holm L, Rosenstrom P (2010) Dali server: Conservation mapping in 3D. Nucleic Acids Research 38(Web Server issue):W545-549.
24. Halaby DM, Poupon A, Mornon J (1999) The immunoglobulin fold family: Sequence analysis and 3D structure comparisons. Protein Eng 12(7):563-571.
25. Adams EJ, et al. (2007) Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc Natl Acad Sci USA 104(24):10128-10133.
26. Natarajan K, et al. (2006) Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J Mol Biol 358(1):157-171.
27. Rudolph MG, Stanfield RL, Wilson IA (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24:419-466.
28. Steinle A, et al. (2001) Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 53(4):279-287.
29. Müller S, Zocher G, Steinle A, Stehle T (2010) Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands. PLoS Pathog 6(1):e1000723.
30. Radaev S, Sun PD (2003) Structure and function of natural killer cell surface receptors. Annu Rev Biophys Biomol Struct 32:93-114.
31. Wang J, et al. (2002) Binding of the natural killer cell inhibitory receptor Ly49A to its major histocompatibility complex class I ligand. Crucial contacts include both H-2Dd AND beta 2-microglobulin. J Biol Chem 277(2):1433-1442.
32. Li P, et al. (2001) Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol 2(5):443-451.
33. Gewurz BE, et al. (2001) Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc Natl Acad Sci USA 98(12):6794-6799.
34. Yang Z, Bjorkman PJ (2008) Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor. Proc Natl Acad Sci USA 105(29):10095-10100.
35. McFarland BJ, Strong RK (2003) Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: Not induced fit but rigid adaptation. Immunity 19(6):803-812.
36. O'Callaghan CA, Cerwenka A, Willcox BE, Lanier LL, Bjorkman PJ (2001) Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity 15(2):201-211.
37. Margulies DH (2003) Molecular interactions: Stiff or floppy (or somewhere in between?). Immunity 19(6):772-774.
38. Sloan VS, et al. (1995) Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375(6534):802-806.
39. Liljedahl M, et al. (1996) HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J 15(18):4817-4824.
40. Yoon T, et al. (2012) Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis. Proc Natl Acad Sci USA 109(28):11276-11281.
41. Zwart W, et al. (2005) Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape. Immunity 22(2):221-233.
42. Wang R, Natarajan K, Margulies DH (2009) Structural basis of the CD8 alpha beta/MHC class I interaction: Focused recognition orients CD8 beta to a T cell proximal position. J Immunol 183(4):2554-2564.
43. Revilleza MJ, et al. (2011) How the virus outsmarts the host: Function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance. J Biomed Biotechnol 2011:724607.
44. Samarakoon A, Chu H, Malarkannan S (2009) Murine NKG2D ligands: "Double, double toil and trouble". Mol Immunol 46(6):1011-1019.
45. Kondo M, et al. (2010) Comparative genomic analysis of mammalian NKG2D ligand family genes provides insights into their origin and evolution. Immunogenetics 62(7):441-450.
46. Eagle RA, Traherne JA, Ashiru O, Wills MR, Trowsdale J (2006) Regulation of NKG2D ligand gene expression. Hum Immunol 67(3):159-169.
47. Chalupny NJ, Rein-Weston A, Dosch S, Cosman D (2006) Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun 346(1):175-181.
48. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods in EnzymologyCarter CW, Jr, Sweet RM (Academic, New York), Vol 276: Macromolecular Crystallography, part A, pp 307-326.
49. Collaborative Computational Project, Number 4 (1994) The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50(Pt 5):760-763.
50. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta Crystallographica. Section D, Biological Crystallography 60(Pt 12 Pt 1):2126-2132.
51. Brunger AT (2007) Version 1.2 of the Crystallography and NMR system. Nat Protoc 2(11):2728-2733.
52. Adams PD, et al. (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66(Pt 2):213-221.
53. Chen VB, et al. (2010) MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66(Pt 1):12-21.
54. Laskowski RA, et al. (1997) PDBsum: A Web-based database of summaries and analyses of all PDB structures. Trends Biochem Sci 22(12):488-490.
55. Svitel J, Balbo A, Mariuzza RA, Gonzales NR, Schuck P (2003) Combined affinity and rate constant distributions of ligand populations from experimental surface binding kinetics and equilibria. Biophys J 84(6):4062-4077.